Skip to main content
DNA Labs India

PC Gene Pyruvate carboxylase deficiency NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

PC Gene Pyruvate carboxylase deficiency NGS Genetic Test

Short Name: PC Gene NGS Test

Also known as: PC Gene Mutation Test, Pyruvate Carboxylase Deficiency DNA Test, PC Enzyme Deficiency Genetic Test, PC Gene Sequencing Test

PC Gene Pyruvate carboxylase deficiency NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS), Sanger Confirmation of Variants on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 Weeks from sample receipt at laboratory. Free home collection in 300+ cities across India.

Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this test is to identify pathogenic or likely pathogenic mutations in the PC gene that cause pyruvate carboxylase deficiency. It is used to confirm a clinical diagnosis, guide treatment decisions, enable carrier testing for family members, support prenatal or preimplantation genetic diagnosis in at-risk families, and provide information for genetic counselling regarding recurrence risk.

Test Code
1801
CPT Code
81479
ICD Code
E74.4
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 Weeks from sample receipt at laboratory
Fasting Required
No
Method
Next-Generation Sequencing (NGS), Sanger Confirmation of Variants
Step 1

Sample Collection

No special preparation is required. Ensure that a clinical history form and informed consent are completed. If the patient has had a recent blood transfusion, inform the laboratory. Genetic counselling is recommended prior to testing.

Method: Venipuncture / Finger-prick (FTA Card)

Step 2

Laboratory Analysis

A trained phlebotomist will collect 3-5 mL of venous blood in an EDTA (lavender-top) tube via standard venipuncture technique. Alternatively, one drop of blood on an FTA card may be used. The sample will be labeled with patient identifiers and stored at ambient temperature for transport.

Step 3

Report Delivery

The blood sample is transported to the DNA Labs India facility under controlled ambient conditions. DNA extraction, library preparation, and NGS sequencing are performed in a CLIA/NABL-accredited molecular genetics laboratory. Reports are delivered within 3 to 4 weeks.

Timeline: 3 to 4 Weeks from sample receipt at laboratory

Patient Instructions

1
Before the Test:A genetic counselling session is recommended before testing. Provide a detailed clinical history of the patient including symptoms, age of onset, family history, and consanguinity. A pedigree chart of affected family members should be drawn. No fasting or special dietary preparation is needed.
2
During the Test:A blood sample (3-5 mL in EDTA tube) or a drop of blood on an FTA card is collected via standard venipuncture or finger-prick. The procedure takes approximately 5-10 minutes and is minimally invasive. The sample is labeled and shipped to the laboratory for processing.
3
After the Test:After sample collection, the patient may resume normal activities immediately. The sample undergoes DNA extraction, library preparation, NGS sequencing, bioinformatics analysis, and variant interpretation in the laboratory. The clinical report is generated and reviewed by a certified geneticist before release. Reports are typically available within 3 to 4 weeks.

About This Test

Who Should Get This Test

The purpose of this test is to identify pathogenic or likely pathogenic mutations in the PC gene that cause pyruvate carboxylase deficiency. It is used to confirm a clinical diagnosis, guide treatment decisions, enable carrier testing for family members, support prenatal or preimplantation genetic diagnosis in at-risk families, and provide information for genetic counselling regarding recurrence risk.

How to Prepare

  • Collect 3-5 mL venous blood in an EDTA (lavender-top) tube
  • Alternatively, apply one drop of blood onto the provided FTA card
  • Do NOT use heparin (green-top) tubes as heparin inhibits PCR
  • Label the sample clearly with patient name, date of birth, and sample ID
  • Store and transport at ambient room temperature (15-30°C)
  • Ship to laboratory within 48 hours of collection

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Pyruvate carboxylase deficiency is a serious inborn error of metabolism presenting with severe lactic acidosis, developmental delay, and neurological impairment in infancy. Early genetic confirmation through NGS testing of the PC gene allows timely initiation of supportive therapies, metabolic management, and accurate genetic counselling for affected families. I recommend this test for any infant or child presenting with unexplained metabolic acidosis, failure to thrive, and neurological regression."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume3-5 mL whole blood
ContainerEDTA (Lavender top) tube or FTA Card
Collection MethodVenipuncture / Finger-prick (FTA Card)

Sample Stability

Whole blood in EDTA: stable up to 7 days at 15-30°C
FTA Card: stable at room temperature for several years
Extracted DNA: stable at -20°C for long-term storage
Sample Rejection Criteria:
  • Sample collected in heparin anticoagulant tube
  • Clotted or hemolyzed blood sample
  • Insufficient sample volume (less than 2 mL)
  • Unlabeled or mislabeled specimen
  • Sample older than 7 days at ambient temperature

Understanding Your Results

The results of the PC Gene Pyruvate Carboxylase Deficiency NGS Genetic Test are interpreted in the context of the patient's clinical presentation, family history, and biochemical findings. Variants are classified according to ACMG/AMP guidelines into five categories. A definitive diagnosis requires identification of biallelic (homozygous or compound heterozygous) pathogenic or likely pathogenic variants in the PC gene. Genetic counselling is strongly recommended to discuss the implications of the results for the patient and family members.
📊

Pathogenic or Likely Pathogenic variant(s) detected (biallelic)

Confirms diagnosis of pyruvate carboxylase deficiency. Counselling and metabolic management should be initiated.

📊

Pathogenic or Likely Pathogenic variant detected (single heterozygous)

Patient is a carrier. Additional testing (MLPA, parental studies) may be needed to identify a second variant.

📊

Variant of Uncertain Significance (VUS) detected

The clinical significance is unknown at this time. Correlation with clinical findings, family studies, and functional data is recommended.

📊

No pathogenic variants detected

PC gene mutations were not identified by this sequencing method. Does not entirely exclude PC deficiency if caused by deep intronic, regulatory, or CNV changes. Further clinical evaluation is advised.

📊

Carrier status identified (for family screening)

Heterozygous carrier of a pathogenic variant. Risk to offspring should be discussed during genetic counselling.

⚠️ When to Consult a Doctor:

Consult your physician or a clinical geneticist if your child presents with unexplained metabolic acidosis, developmental delay, poor feeding, seizures, or failure to thrive. If a family member has been diagnosed with pyruvate carboxylase deficiency, genetic counselling and carrier testing should be discussed. If test results return a VUS or unexpected finding, a genetic counsellor can help interpret the significance and guide next steps.

Limitations

  • This test does not detect large deletions or duplications; MLPA or array CGH may be needed for CNV analysis
  • Deep intronic variants, regulatory region mutations, and mitochondrial DNA variants are not covered
  • Variants of uncertain significance (VUS) may be identified and may require further family studies or functional assays
  • Negative result does not completely exclude pyruvate carboxylase deficiency if caused by variants in other regulatory genes
  • Pseudogene interference or regions of high homology may result in gaps in coverage

Risks & Considerations

  • Minor bruising or discomfort at the venipuncture site
  • Risk of anxiety related to genetic test results (genetic counselling recommended pre- and post-test)
  • Possibility of identifying variants of uncertain significance (VUS) which may cause confusion without proper counselling
  • Potential psychosocial impact of carrier status or presymptomatic findings on the family

Interfering Factors

  • Degraded or insufficient DNA quality may affect sequencing results
  • Recent blood transfusion (within 4 weeks) may dilute patient's own DNA
  • Contamination of sample during collection or transport
  • Heparin anticoagulant (use EDTA instead, as heparin can inhibit PCR-based library preparation)

Compare With Similar Tests

TestPC Gene Pyruvate carboxylase deficiency NGS Genetic Test
ComparisonPC Gene Pyruvate carboxylase deficiency NGS Genetic Test

Frequently Asked Questions

What is pyruvate carboxylase deficiency?
Pyruvate carboxylase deficiency is a rare autosomal recessive genetic disorder caused by mutations in the PC gene. It affects the body's ability to convert pyruvate to oxaloacetate, disrupting gluconeogenesis and TCA cycle function. This leads to lactic acidosis, developmental delay, and neurological impairment.
What does the PC Gene NGS Genetic Test detect?
This test uses Next-Generation Sequencing (NGS) to analyze the entire coding region and splice sites of the PC gene. It identifies point mutations, small insertions, and small deletions that may cause pyruvate carboxylase deficiency. Detected variants are classified according to ACMG guidelines.
Who should get this genetic test?
This test is recommended for individuals with clinical symptoms of pyruvate carboxylase deficiency such as unexplained lactic acidosis, developmental delay, hypotonia, seizures, or failure to thrive. It is also recommended for carrier testing in parents or siblings of an affected individual and for prenatal planning.
What sample is required for this test?
The test requires 3-5 mL of venous blood collected in an EDTA (lavender-top) tube, or extracted DNA, or one drop of blood on an FTA card. No fasting is required for sample collection.
How much does the PC Gene NGS Genetic Test cost?
The test costs INR 20,000 at DNA Labs India. This price includes free home sample collection across India, NGS sequencing, a detailed clinical genetic report, and access to raw data files (FASTQ and VCF formats).
How long does it take to get the results?
The report turnaround time is 3 to 4 weeks from the date of sample receipt at the laboratory. Reports are delivered via the online portal, email, and WhatsApp.
Is home sample collection available for this test?
Yes, DNA Labs India offers free home sample collection for the PC Gene NGS Genetic Test across all major cities in India including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and many more. You can book online for convenient at-home collection.
Can this test be used for prenatal diagnosis?
If the specific PC gene mutations in the family are already known from prior testing, targeted prenatal testing can be arranged. Discuss this option with your clinical geneticist or genetic counsellor.
What if the test result shows a Variant of Uncertain Significance (VUS)?
A VUS means the clinical significance of the detected variant is currently unknown. Your geneticist will correlate the finding with clinical and family data. Additional family studies, functional assays, or periodic reclassification may be recommended.
Does DNA Labs India share raw sequencing data?
Yes. DNA Labs India is the only lab that transparently shares Raw Data, FASTQ, and VCF files along with the conclusive clinical report for the PC Gene Pyruvate Carboxylase Deficiency NGS Genetic Test.
Is this test covered under government health insurance schemes?
Coverage for NGS genetic tests under government schemes like PMJAY, CGHS, ECHS, and ESIC is generally limited and may require special approval. It is advisable to check with your scheme administrator or hospital regarding specific coverage and reimbursement policies.
What is the difference between this test and whole exome sequencing?
The PC Gene NGS test is a targeted test that analyzes only the PC gene, making it more focused and cost-effective at INR 20,000. Whole exome sequencing (WES) analyzes all ~20,000 protein-coding genes and is broader but more expensive. For suspected PC deficiency, a targeted gene test is recommended as the first step.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.